Creating Access to Appropriate Therapeutic Pharmacy Alternatives
Wednesday April 27th, 11-12 EST
Generics are Coming to Market for HIV and Humira. How does an Employer Ensure they Maximize this Opportunity?
In the next few years there are some big drugs that will have biosimilar or generic alternatives that are complete therapeutic alternatives coming to market, but employers may not appreciate their impact on their finances due to market influencers.
During this session, you will learn: What market influencers exist that will impact your ability to get these meds on your formulary
How the brand manufacturers and PBMs position things to make the impact of the alternative medications less impactful
Understand options to take control and secure your plan members access to the medications they deserve
Establish PBM contracts that don’t create barriers to your own success
Brenda Motheral, CEO of Archimedes
Barbara Brungess, Principal of Arevema
Alex Oshmyansky- CEO, Cost Plus Drugs